ArcticZymes AS is pleased to announce the launch of dsDNase Triton FREE. This launch is a continuing step towards maintaining a completely EU REACH compliant product portfolio after Triton X-100 becomes subject to authorisation in January 2021 and facilitate a smooth… read more »
SAN HQ developed by ArcticZymes has quickly found its place as a valuable tool in manufacture of gene-delivery vehicles (viral vectors) applicable in gene therapy. In cooperation with the Cell and Gene Therapy Catapult, a centre of excellence in innovation,… read more »
ArcticZymes AS is pleased to announce the launch of dsDNase Glycerol-free Triton FREE. This launch is a continuing step towards maintaining a completely EU REACH compliant product portfolio after Triton X-100 becomes subject to authorisation in January 2021 and facilitate… read more »View our news archive